Diana Swift is a contributing writer for various medical publications, including MedPage Today, Medscape, and MDEdge. With a focus on medical news and research, Diana covers a wide range of topics including oral health, blood pressure monitoring, exercise benefits, cancer treatment, and challenges in managing specific diseases.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Diana Swift's coverage primarily focuses on healthcare, pharmaceuticals, and health and wellbeing. She often cites data to support her articles. For effective outreach, consider offering pitches that provide access to new and relevant scientific data or studies related to the topics she covers.
Given her focus on clinical challenges within specific diseases such as Crohn's disease and breast cancer, Diana may be interested in receiving pitches from medical professionals with expertise in these areas who can offer insights into recent research findings or emerging treatment approaches.
As Diana does not have a specified geographic focus, it is valuable to ensure that any pitched content has broad relevance across different regions or includes global perspectives.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
The experimental monoclonal antibody tulisokibart safely induced clinical remission in a phase 2 randomized trial of moderately to severely active
The experimental monoclonal antibody tulisokibart safely induced clinical remission in a phase 2 randomized trial of moderately to severely active ulcerative colitis.
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
CHICAGO – A recent history of GI bleeding or malignancy may not be a valid contraindication to thrombolytic therapy in patients with an acute ischemic stroke, based on a review of outcomes from more than 40,000 U.S. stroke patients.
Evidence suggested there is little risk in administering the live rotavirus vaccine to the babies of mothers on biologics during pregnancy for inflammatory bowel disease.
Vaccination against human papilloma virus (HPV), a group of more than 200 viruses infecting at least 50% of sexually active people over their lifetimes, has proved more than 90% effective for preventing several diseases caused by high-risk HPV types.
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
The majority of patients may safely take glucagon -like peptide 1 receptor agonists (GLP-1 RAs) before elective surgery and gastrointestinal endoscopies, according to updated guidance from five medical societies.
Interventional procedures should be minimally invasive and uterus sparing.
(833) 317-6278 
